Radiomic: Clinical Trials

3 trials for Radiomic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting. .

Follow Radiomic: new trials by email Literature Review of Radiomic trials Research Report on Radiomic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
No intervention (observational study) - Uterine Fibroid, Uterine Sarcoma
Not yet recruitingTongji Hospital5002026-09-302026-10-08
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
Trastuzumab deruxtecan (DS-8201a) - Radiomic, Radiomics
RecruitingFondazione IRCCS Istituto Nazionale dei Tumori, Milano5002024-02-012025-06-22
10-year Retrospective Study of Oral and Maxillofacial Squamous Cell Carcinoma
The Resnet50 deep learning (DL) model - HNSCC, AI
CompletedSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3192023-05-102024-04-16

Narrower conditions

Breast Neoplasms (1)  ·  Leiomyoma (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Muscle Tissue (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Observation (1)  ·  trastuzumab deruxtecan (1)

Sponsors

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Tongji Hospital (1)

Countries

China (1)  ·  Italy (1)